共 50 条
- [41] The in vitro characterization of SLV308:: A novel dopamine D2/D3 partial agonist and 5-HT1A full agonist for the treatment of Parkinson's diseaseMOVEMENT DISORDERS, 2006, 21 : S79 - S80McCreary, ACGlennon, JGReindeers, JHHesselink, Mvan Scharrenburg, G
- [42] A summary of the in vitro pharmacology of pardoprunox (SLV308): A novel dopamine D2/D3 partial agonist and 5-HT1A agonist for the treatment of Parkinson's diseasePARKINSONISM & RELATED DISORDERS, 2007, 13 : S139 - S140McCreary, A.Glennon, J.Reinders, J. -H.Hesselink, M.van Scharrenburg, G.
- [43] Pharmacological Properties of 2-((R-5-Chloro-4-methoxymethylindan-1-yl)-1H-imidazole (PF-3774076), a Novel and Selective α1A-Adrenergic Partial Agonist, in in Vitro and in Vivo Models of Urethral FunctionJOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2009, 330 (03): : 892 - 901Conlon, KellyChristy, ClareWestbrook, SimonWhitlock, GavinRoberts, LeeStobie, AlanMcMurray, Gordon
- [44] Pharmacological evaluation of the anxiolytic-like effects of EMD 386088, a partial 5-HT6 receptor agonist, in the rat elevated plus-maze and Vogel conflict testsNEUROPHARMACOLOGY, 2014, 85 : 253 - 262Jastrzebska-Wiesek, MagdalenaSiwek, AgataPartyka, AnnaKubacka, MonikaMogilski, SzczepanWasik, AnnaKolaczkowski, MarcinWesolowska, Anna
- [45] Partial agonist activity of R3(BΔ23-27)R/I5 at RXFP3-Investigation of in vivo and in vitro pharmacologyEUROPEAN JOURNAL OF PHARMACOLOGY, 2015, 747 : 123 - 131Kristensson, LisbethMayer, GaellPloj, KarolinaWetterlund, MartinaArlbrandt, SusanneBjorquist, AnnaWissing, Britt-MarieCastaldo, MarieLarsson, Niklas
- [46] CONFORMATIONALLY DEFINED ADRENERGIC AGENTS .5. RESOLUTION, ABSOLUTE-CONFIGURATION, AND PHARMACOLOGICAL CHARACTERIZATION OF THE ENANTIOMERS OF 2-(5,6-DIHYDROXY-1,2,3,4-TETRAHYDRO-1-NAPHTHYL)IMIDAZOLINE - A POTENT AGONIST AT ALPHA-ADRENOCEPTORSJOURNAL OF MEDICINAL CHEMISTRY, 1987, 30 (06) : 1011 - 1017DEBERNARDIS, JFKERKMAN, DJARENDSEN, DLBUCKNER, SAKYNCL, JJHANCOCK, AA
- [47] An in vivo pharmacological evaluation of pardoprunox (SLV308) - A novel combined dopamine D2/D3 receptor partial agonist and 5-HT1A receptor agonist with efficacy in experimental models of Parkinson's diseaseEUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 (08) : 582 - 593Jones, C. A.Johnston, L. C.Jackson, M. J.Smith, L. A.van Scharrenburg, G.Rose, S.Jenner, P. G.McCreary, A. C.
- [48] F15063, a potential antipsychotic with D2/D3 antagonist, 5-HT1A agonist and D4 partial agonist properties:: (I) in vitro receptor affinity and efficacy profileBRITISH JOURNAL OF PHARMACOLOGY, 2007, 151 (02) : 237 - 252Newman-Tancredi, A.Assie, M-BMartel, J-CCosi, C.Slot, L. BruinsPalmier, C.Rauly-Lestienne, I.Colpaert, F.Vacher, B.Cussac, D.
- [49] THE PHARMACOLOGICAL ASSESSMENT OF RS-86 (2-ETHYL-8-METHYL-2,8-DIAZASPIRO-[4,5]-DECAN-1,3-DION HYDROBROMIDE) - A POTENT, SPECIFIC MUSCARINIC ACETYLCHOLINE-RECEPTOR AGONISTEUROPEAN JOURNAL OF PHARMACOLOGY, 1986, 125 (01) : 45 - 62PALACIOS, JMBOLLIGER, GCLOSSE, AENZ, AGMELIN, GMALANOWSKI, J
- [50] Pharmacological characterization of the muscarinic agonist (3R,4R)-3-(3-Hexylsulfanyl-pyrazin-2-yloxy)-1-azabicyclo[2.2.1] heptane (WAY-132983) in in vitro and in vivo models of chronic painJOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2007, 322 (03): : 1294 - 1304Sullivan, Nicole R.Leventhal, LizaHarrison, JamesSmith, Valerie A.Cummons, Terri A.Spangler, Taylor B.Sun, Shaiu-ChingLu, PeiminUveges, Albert J.Strassle, Brian W.Piesla, Michael J.Ramdass, RanaBarry, AlenaSchantz, JonathanAdams, WilliamWhiteside, Garth T.Adedoyin, AdedayoJones, Philip G.